GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company says new ...
Real-world optimization problems often require an external “modeling engine” that computes fitnesses or data that are then input to an objective function. These programs often have much longer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results